CN106399261A - Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers - Google Patents

Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers Download PDF

Info

Publication number
CN106399261A
CN106399261A CN201610861307.XA CN201610861307A CN106399261A CN 106399261 A CN106399261 A CN 106399261A CN 201610861307 A CN201610861307 A CN 201610861307A CN 106399261 A CN106399261 A CN 106399261A
Authority
CN
China
Prior art keywords
reactor
culture
microcarrier
mouth disease
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610861307.XA
Other languages
Chinese (zh)
Inventor
王建超
苟晨
赵子威
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianxinhe (suzhou) Biotechnology Co Ltd
Original Assignee
Tianxinhe (suzhou) Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianxinhe (suzhou) Biotechnology Co Ltd filed Critical Tianxinhe (suzhou) Biotechnology Co Ltd
Priority to CN201610861307.XA priority Critical patent/CN106399261A/en
Publication of CN106399261A publication Critical patent/CN106399261A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32121Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers. The method comprises the following steps: reviving BHK21 cells, carrying out adherent culture on the cells in a square bottle, digesting the cells, amplifying the cells and cultivating the cells by transferring the cells into another bottle; adhering the BHK21 cells to the wall to gradually carry out enlarge cultivation until needed cell density is reached in a reactor; adding the treated microcarriers into the reactor, wherein dosage of the microcarriers is 1 to 5g/L; digesting the BHK21 cells, transferring the BHK21 cells into a reactor to cultivate through the microcarriers, wherein sampling, digesting and counting density is 1 to 4*10<9>/L, viruses are inoculated by 1 to 5 percent, cell activity is less than or equal to 5 percent; harvesting a culture solution, refrigerating the culture solution at a low temperature for later use; and after receiving the virus through a microcarrier reactor, detecting LD50. The method has the characteristics of high degree of automation, high virus titer of seed virus, good seed virus consistency, great yield, and solves the problems such as poor product quality stability and low yield in production of the foot-and-mouth disease seed virus.

Description

The method that microcarrier suspension culture BHK21 cell produces foot and mouth disease kind poison
Technical field
The present invention relates to field of cell culture is and in particular to a kind of microcarrier suspension culture BHK21 cell produces foot and mouth disease The method planting poison.
Background technology
Preparation kind poison is the important process link of production of vaccine.The method preparing vaccine kind poison at present includes the life of rolling bottle technique Produce and suspension process produces two kinds:Rolling bottle technique preparation kind poison, a steady quality, malicious valency preferably but complex operation, consume a large amount of people Work, specific yield is little, and endotoxin is difficult to control to;Suspension process can be mass-produced vaccine kind poison, operates relative ease, but malicious valency Relatively low it is difficult to reach ideal effect.
Content of the invention
It is an object of the invention to the problem above overcoming prior art to exist, provide microcarrier suspension culture BHK21 thin The method that born of the same parents produce foot and mouth disease kind poison, the present invention adopts bioreactor microcarrier culture vaccine kind poison, the micro- load of bioreactor Body culture viral vaccine kind poison, has high degree of automation, kind poison poison valency is high, it is good to plant poison concordance, and the big feature of yield.
For realizing above-mentioned technical purpose, reach above-mentioned technique effect, the present invention is achieved through the following technical solutions:
A kind of method that microcarrier suspension culture BHK21 cell produces foot and mouth disease kind poison, it comprises the following steps:
S101 is by BHK21 cell recovery, square vase adhere-wall culture, then amplifies spinner culture through digestion;
S102 BHK21 cell attachment progressively amplification culture, to cell density needed for reactor;
The microcarrier that S103 reactor addition was processed, microcarrier consumption is 1-5g/L;
S104 BHK21 cell dissociation accesses the culture of reactor microcarrier, and sampling digestion count density reaches 1-4 × 109 Individual/L, connects malicious 1-5%, cell viability≤5%, harvests culture fluid, deepfreeze is standby;
After S105 microcarrier reactor receives poison, detect LD50.
Further include, in S101, BHK21 cell, after recovery, is carried out using MEM+8% new-born calf serum culture medium Ferrum wall is cultivated, and is amplified to spinner culture through pancreatin digestion.
Further include, in S102, cell counting, 1.8-7 × 108/ L cell concentration is inoculated in 5L bioreactor.
Further include, in S103, control the condition of reactor:36-38 DEG C, pH 6.8-7.2, DO20-50%, inoculation After 48h, sampling, violet staining carries out cell counting.
Further include, in S104, BHK21 cell includes in the step of reactor suspension amplification culture:
In S201 5L reactor, when cell density reaches 1-4 × 109During/L, settle microcarrier, discharge culture medium, use PBS washs, each 2L, washs 2 times, adds pancreatin Digestive system, digests while stirring, determines that after reaching digestion effect, addition contains Blood serum medium terminates pancreatin digestion, and proceeds in 100L reactor;
1-5g/L containing microcarrier in S202 100L reactor, volume of culture 70-100L, control reactor condition:36-38 DEG C, pH6.8-7.2, DO20-50%, in the above conditions, cultivated, and after inoculation 48h, sampling, violet staining is entered Row cell counting, calculates cell growth state, when cell density reaches 1-4 × 109During/L, digested with same mode of operation and connect Plant to 500L reactor;
1-5g/L containing microcarrier in S203 500L reactor, volume of culture 300-500L, control reactor condition:36-38 DEG C, pH6.8-7.2, DO20-50%, in the above conditions, cultivated, and after inoculation 48h, sampling, violet staining is entered Row cell counting, calculates cell growth state, when cell density reaches 1-4 × 109During/L, foot and mouth disease kind is inoculated with 0.5-2% Poison.
Further include, in S105, in 500L reactor inoculation kind poison after, the condition setting reactor as 36-38 DEG C, PH is 7.2-7.5, DO20-50%, carries out kind of a poison and increases poison, timing sampling is observed, during DANGMING explict occurrence cytopathy, increasing poison of receiving Product, is placed in -20--80 DEG C of freezen protective, carries out LD50 detection to product, and LD50 reaches 10^7~7.75/0.2ml.
Further include, step S101-105 is used for producing any foot-and-mouth disease vaccine kind poison.
Further include, step S101-105 is used for producing any hypotype foot-and-mouth disease vaccine kind poison.
The invention has the beneficial effects as follows:
The easily operated control of the method for the present invention, has high degree of automation, kind poison poison valency is high, it is good to plant poison concordance, and The big feature of yield, and solve the problems, such as foot and mouth disease kind poison produce in product quality stability difference and yield poorly.
Described above is only the general introduction of technical solution of the present invention, in order to better understand the technological means of the present invention, And can be practiced according to the content of description, below with presently preferred embodiments of the present invention and coordinate accompanying drawing describe in detail as after. The specific embodiment of the present invention is shown in detail in by following examples and its accompanying drawing.
Brief description
In order to be illustrated more clearly that the technical scheme in embodiment of the present invention technology, below will be in the description of embodiment technology The accompanying drawing of required use be briefly described it should be apparent that, drawings in the following description be only the present invention some are real Apply example, for those of ordinary skill in the art, on the premise of not paying creative work, can also be according to these accompanying drawings Obtain other accompanying drawings.
Fig. 1 is method of the present invention flow chart.
Specific embodiment
Below in conjunction with the accompanying drawing in the embodiment of the present invention, the technical scheme in the embodiment of the present invention is carried out clear, complete Site preparation description is it is clear that described embodiment is only a part of embodiment of the present invention, rather than whole embodiments.It is based on Embodiment in the present invention, it is every other that those of ordinary skill in the art are obtained under the premise of not making creative work Embodiment, broadly falls into the scope of protection of the invention.
Embodiment
Produce foot and mouth disease kind poison with reference to shown in Fig. 1, disclosing a kind of microcarrier suspension culture BHK21 cell in the present embodiment Method, it comprises the following steps:
S101 BHK21 cell, after recovery, carries out ferrum wall culture using MEM+8% new-born calf serum culture medium, and warp Cross pancreatin digestion and be amplified to spinner culture.
S102 BHK21 cell attachment progressively amplification culture, to cell density needed for reactor, cell counting, 1.8-7 × 108/ L cell concentration is inoculated in 5L bioreactor.
The microcarrier that S103 reactor addition was processed, microcarrier consumption is 1-5g/L;Wherein, control the bar of reactor Part:36-38 DEG C, pH 6.8-7.2, DO20-50%, after inoculation 48h, sampling, violet staining carries out cell counting.
S104 BHK21 cell dissociation accesses the culture of reactor microcarrier, and sampling digestion count density reaches 1-4 × 109 Individual/L, connects malicious 1-5%, cell viability≤5%, harvests culture fluid, deepfreeze is standby.
In S104, BHK21 cell includes in the step of reactor suspension amplification culture:
In S201 5L reactor, when cell density reaches 1-4 × 109During/L, settle microcarrier, discharge culture medium, use PBS washs, each 2L, washs 2 times, adds pancreatin Digestive system, digests while stirring, determines that after reaching digestion effect, addition contains Blood serum medium terminates pancreatin digestion, and proceeds in 100L reactor;
1-5g/L containing microcarrier in S202 100L reactor, volume of culture 70-100L, control reactor condition:36-38 DEG C, pH6.8-7.2, DO20-50%, in the above conditions, cultivated, and after inoculation 48h, sampling, violet staining is entered Row cell counting, calculates cell growth state, when cell density reaches 1-4 × 109During/L, digested with same mode of operation and connect Plant to 500L reactor;
1-5g/L containing microcarrier in S203 500L reactor, volume of culture 300-500L, control reactor condition:36-38 DEG C, pH6.8-7.2, DO20-50%, in the above conditions, cultivated, and after inoculation 48h, sampling, violet staining is entered Row cell counting, calculates cell growth state, when cell density reaches 1-4 × 109During/L, foot and mouth disease kind is inoculated with 0.5-2% Poison.
After S105 inoculates kind of poison in 500L reactor, as 36-38 DEG C, pH is 7.2-7.5 to the condition setting reactor, DO20-50%, carries out kind of a poison and increases poison, timing sampling is observed, during DANGMING explict occurrence cytopathy, the malicious product of increasing of receiving, be placed in- 20--80 DEG C of freezen protective, carries out LD50 detection to product, and as shown in table 1, LD50 reaches 10^7~7.75/0.2ml.
Above-mentioned steps S101-105 are used for producing any foot-and-mouth disease vaccine kind poison, or produce any hypotype foot-and-mouth disease vaccine kind Poison.
Table 1 rolling bottle kind poison and kind of the Conium maculatum L. number that suspends compare
The easily operated control of said method, has high degree of automation, kind poison poison valency is high, it is good to plant poison concordance, and yield Big feature, and solve the problems, such as foot and mouth disease kind poison produce in product quality stability difference and yield poorly.
Described above to the disclosed embodiments, makes professional and technical personnel in the field be capable of or uses the present invention. Multiple modifications to these embodiments will be apparent from for those skilled in the art, as defined herein General Principle can be realized without departing from the spirit or scope of the present invention in other embodiments.Therefore, the present invention It is not intended to be limited to the embodiments shown herein, and be to fit to and principles disclosed herein and features of novelty phase one The scope the widest causing.

Claims (8)

1. a kind of microcarrier suspension culture BHK21 cell produces the method for foot and mouth disease kind poison it is characterised in that it includes following step Suddenly:
S101 is by BHK21 cell recovery, square vase adhere-wall culture, then amplifies spinner culture through digestion;
S102 BHK21 cell attachment progressively amplification culture, to cell density needed for reactor;
The microcarrier that S103 reactor addition was processed, microcarrier consumption is 1-5g/L;
S104 BHK21 cell dissociation accesses the culture of reactor microcarrier, and sampling digestion count density reaches 1-4 × 109Individual/L, connects Malicious 1-5%, cell viability≤5%, harvest culture fluid, deepfreeze is standby;
After S105 microcarrier reactor receives poison, detect LD50.
2. the method that microcarrier suspension culture BHK21 cell according to claim 1 produces foot and mouth disease kind poison, its feature exists In, in S101, BHK21 cell, after recovery, carries out ferrum wall culture using MEM+8% new-born calf serum culture medium, and passes through Pancreatin digestion is amplified to spinner culture.
3. the method that microcarrier suspension culture BHK21 cell according to claim 1 produces foot and mouth disease kind poison, its feature exists In, in S102, cell counting, 1.8-7 × 108/ L cell concentration is inoculated in 5L bioreactor.
4. the method that microcarrier suspension culture BHK21 cell according to claim 1 produces foot and mouth disease kind poison, its feature exists In, in S103, the condition of control reactor:36-38 DEG C, pH 6.8-7.2, DO20-50%, after inoculation 48h, sampling, crystal violet Dyeing carries out cell counting.
5. the method that microcarrier suspension culture BHK21 cell according to claim 1 produces foot and mouth disease kind poison, its feature exists In, in S104, BHK21 cell includes in the step of reactor suspension amplification culture:
In S201 5L reactor, when cell density reaches 1-4 × 109During/L, settle microcarrier, discharge culture medium, washed using PBS Wash, each 2L, wash 2 times, add pancreatin Digestive system, digest while stirring, determine after reaching digestion effect, add containing serum training Foster base terminates pancreatin digestion, and proceeds in 100L reactor;
1-5g/L containing microcarrier in S202 100L reactor, volume of culture 70-100L, control reactor condition:36-38 DEG C, PH6.8-7.2, DO20-50%, in the above conditions, are cultivated, and after inoculation 48h, sampling, violet staining is carried out carefully Born of the same parents count, and calculate cell growth state, when cell density reaches 1-4 × 109During/L, digested with same mode of operation and be seeded to 500L reactor;
1-5g/L containing microcarrier in S203 500L reactor, volume of culture 300-500L, control reactor condition:36-38 DEG C, PH6.8-7.2, DO20-50%, in the above conditions, are cultivated, and after inoculation 48h, sampling, violet staining is carried out carefully Born of the same parents count, and calculate cell growth state, when cell density reaches 1-4 × 109During/L, with 0.5-2% inoculation foot and mouth disease kind poison.
6. the method that microcarrier suspension culture BHK21 cell according to claim 1 produces foot and mouth disease kind poison, its feature exists In, in S105, after inoculation kind poison in 500L reactor, as 36-38 DEG C, pH is 7.2-7.5 to the condition setting reactor, DO20-50%, carries out kind of a poison and increases poison, timing sampling is observed, during DANGMING explict occurrence cytopathy, the malicious product of increasing of receiving, be placed in- 20--80 DEG C of freezen protective, carries out LD50 detection to product, and LD50 reaches 10^7~7.75/0.2ml.
7. the method that the microcarrier suspension culture BHK21 cell according to any one of claim 1-6 produces foot and mouth disease kind poison, It is characterized in that, step S101-105 is used for producing any foot-and-mouth disease vaccine kind poison.
8. the method that the microcarrier suspension culture BHK21 cell according to any one of claim 1-6 produces foot and mouth disease kind poison, It is characterized in that, step S101-105 is used for producing any hypotype foot-and-mouth disease vaccine kind poison.
CN201610861307.XA 2016-09-29 2016-09-29 Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers Pending CN106399261A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610861307.XA CN106399261A (en) 2016-09-29 2016-09-29 Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610861307.XA CN106399261A (en) 2016-09-29 2016-09-29 Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers

Publications (1)

Publication Number Publication Date
CN106399261A true CN106399261A (en) 2017-02-15

Family

ID=58015697

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610861307.XA Pending CN106399261A (en) 2016-09-29 2016-09-29 Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers

Country Status (1)

Country Link
CN (1) CN106399261A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111979201A (en) * 2020-08-24 2020-11-24 天信和(苏州)生物科技有限公司 Method for improving foot-and-mouth disease virus expression level
CN115386534A (en) * 2022-10-26 2022-11-25 天信和(苏州)生物科技有限公司 Method for culturing BHK21 cells by using serum-free culture medium and application of BHK21 cells in preparation of vaccines

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101875917A (en) * 2009-04-28 2010-11-03 北京清大天一科技有限公司 Method for producing swine fever vaccines by using animal cells cultured by micro-carriers of bio-reactor
CN102178946A (en) * 2011-03-18 2011-09-14 马忠仁 Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production
CN103087995A (en) * 2012-12-28 2013-05-08 杭州国牧生物科技有限公司 Method of preparing foot-and-mouth disease vaccine by using BHK-21 adherent cells
CN103374547A (en) * 2012-07-04 2013-10-30 北京健翔和牧生物科技有限公司 Method for preparing purified foot-and-mouth disease vaccine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101875917A (en) * 2009-04-28 2010-11-03 北京清大天一科技有限公司 Method for producing swine fever vaccines by using animal cells cultured by micro-carriers of bio-reactor
CN102178946A (en) * 2011-03-18 2011-09-14 马忠仁 Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production
CN103374547A (en) * 2012-07-04 2013-10-30 北京健翔和牧生物科技有限公司 Method for preparing purified foot-and-mouth disease vaccine
CN103087995A (en) * 2012-12-28 2013-05-08 杭州国牧生物科技有限公司 Method of preparing foot-and-mouth disease vaccine by using BHK-21 adherent cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张韧 等: "反应器细胞悬浮培养和微载体培养技术在动物疫苗生产中的应用", 《中国兽药杂志》 *
陈文庆 等: "悬浮培养工艺与转瓶培养工艺的比较分析", 《中国兽药杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111979201A (en) * 2020-08-24 2020-11-24 天信和(苏州)生物科技有限公司 Method for improving foot-and-mouth disease virus expression level
CN111979201B (en) * 2020-08-24 2023-05-16 天信和(苏州)生物科技有限公司 Method for improving foot-and-mouth disease virus expression level
CN115386534A (en) * 2022-10-26 2022-11-25 天信和(苏州)生物科技有限公司 Method for culturing BHK21 cells by using serum-free culture medium and application of BHK21 cells in preparation of vaccines
CN115386534B (en) * 2022-10-26 2023-02-21 天信和(苏州)生物科技有限公司 Method for culturing BHK21 cells by using serum-free culture medium and application of BHK21 cells in preparation of vaccines

Similar Documents

Publication Publication Date Title
CN102559617A (en) Method of bioreactor micro-carrier for cultivating human diploid cell to produce viral vaccine
US20210180027A1 (en) Method for Acclimating and Suspending Vero and Second Order Production Process for Virus
CN106047821A (en) Method for producing rotavirus vaccines in large scale by utilizing bioreactor
CN106434571A (en) Method for preparing recombinant adenovirus by WAVE serum-free culture suspension cells
CN101875917A (en) Method for producing swine fever vaccines by using animal cells cultured by micro-carriers of bio-reactor
CN102178946B (en) Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production
CN107267468A (en) A kind of method of serum free suspension culture Pseudorabies virus
CN105969737B (en) A kind of method of large-scale production Rotavirus Vaccine
CN103087995B (en) Method of preparing foot-and-mouth disease vaccine by using BHK-21 adherent cells
CN106399261A (en) Method for producing foot-and-mouth disease seed virus by suspension cultivation on BHK21 cells through microcarriers
CN104894054B (en) A kind of suspension adapted strains of monkey embryo renal epithelial cell Marc 145 and its application in culture reproductive and respiratory syndrome virus, the blue ear viral vaccine of production
CN103555674A (en) Multiple-virus-obtaining process for proliferating porcine reproductive and respiratory syndrome virus by Marc (rhesus monkey kidney cell)-145 cell cultured by microcarriers
CN102743749B (en) Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor
CN105838683A (en) Method for proliferation of mink canine distemper virus by applying novel cell microcarrier
CN101775374B (en) Production method of porcine epidemic diarrhea virus
CN103614333A (en) Method for enlarging cultivation of zooblasts in reactor via collagen microcarriers
CN104593335B (en) The low cells of serum free culture system Marc 145 production pig breeding and the method for respiratory syndrome CH 1R strain virus
CN111662882A (en) Method for proliferating avian influenza virus by MDCK cell line
CN103387958B (en) The application of human embryonic lung fibroblast SV-7 in virus culture
CN107432931B (en) A kind of method that microcarrier culture varicella virus prepares vaccine
CN102526720B (en) Preparation method of influenza virus vaccine
CN102657859A (en) Method for producing avian influenza vaccine by using cells cultured by spherical microcarrier bioreactor
CN105288608A (en) Porcine circovirus 2 type inactivated vaccine continuous harvest and suspension cultivation production method
CN102327609B (en) Production method of encephalitis B vaccine
CN115287269A (en) Method for producing rabies virus by high-density culture of Vero cells by microcarrier

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170215

RJ01 Rejection of invention patent application after publication